Cabilingga, Janelyn B.
HRN: 23-46-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2023
CEFUROXIME 500MG (TAB)
08/02/2023
08/08/2023
PO
500mg
BID
S/p RMLE + Repair
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes